{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,18]],"date-time":"2026-09-18T10:34:35Z","timestamp":1789727675914,"version":"4.0.1"},"reference-count":82,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2004,1,1]],"date-time":"2004-01-01T00:00:00Z","timestamp":1072915200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Curr Neurol Neurosci Rep"],"published-print":{"date-parts":[[2004,1]]},"DOI":"10.1007\/s11910-004-0016-6","type":"journal-article","created":{"date-parts":[[2007,5,25]],"date-time":"2007-05-25T13:39:47Z","timestamp":1180100387000},"page":"74-80","source":"Crossref","is-referenced-by-count":44,"title":["Spinal muscular atrophy"],"prefix":"10.1007","volume":"4","author":[{"given":"Susan T.","family":"Iannaccone","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephen A.","family":"Smith","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Louise R.","family":"Simard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","reference":[{"key":"16_CR1","first-page":"383","volume-title":"The Founders of Child Neurology","author":"H Groger","year":"1990","unstructured":"Groger H: Guido Werdnig In The Founders of Child Neurology. Edited by Ashwal S. San Francisco: Norman Publishing; 1990:383\u2013388."},{"key":"16_CR2","first-page":"644","volume":"24","author":"J Hoffmann","year":"1892","unstructured":"Hoffmann J: Ueber famili\u00e4re progressive spinale muskelatrophie. Arch Psych (Berlin) 1892, 24:644\u2013646.","journal-title":"Arch Psych (Berlin)"},{"key":"16_CR3","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1001\/archneur.1961.00450140022003","volume":"5","author":"RK Byers","year":"1961","unstructured":"Byers RK, Banker BQ: Infantile muscular atrophy. Arch Neurol 1961, 5:140\u2013164.","journal-title":"Arch Neurol"},{"key":"16_CR4","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/0960-8966(94)00075-K","volume":"5","author":"V Dubowitz","year":"1995","unstructured":"Dubowitz V: Chaos in the classification of SMA: a possible resolution. Neuromuscul Disord 1995, 5:3\u20135.","journal-title":"Neuromuscul Disord"},{"key":"16_CR5","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1136\/jmg.15.6.409","volume":"15","author":"JH Pearn","year":"1978","unstructured":"Pearn JH: Incidence, prevalence, and gene frequency studies of chronic childhood spinal muscular atrophy. J Med Genet 1978, 15:409\u2013413.","journal-title":"J Med Genet"},{"key":"16_CR6","doi-asserted-by":"crossref","first-page":"540","DOI":"10.1038\/344540a0","volume":"344","author":"LM Brzustowicz","year":"1990","unstructured":"Brzustowicz LM, Lehner T, Castilla LH, et al.: Genetic mapping of chronic childhood-onset spinal muscular atrophy to chromosome 5q11.2-13.3. Nature 1990, 344:540\u2013541.","journal-title":"Nature"},{"key":"16_CR7","doi-asserted-by":"crossref","first-page":"767","DOI":"10.1038\/344767a0","volume":"344","author":"J Melki","year":"1990","unstructured":"Melki J, Abdelhak S, Sheth P, et al.: Gene for chronic proximal spinal muscular atrophies maps to chromosome 5q. Nature 1990, 344:767\u2013768.","journal-title":"Nature"},{"key":"16_CR8","doi-asserted-by":"crossref","first-page":"823","DOI":"10.1038\/345823a0","volume":"345","author":"TC Gilliam","year":"1990","unstructured":"Gilliam TC, Brzustowicz LM, Castilla LH, et al.: Genetic homogeneity between acute (SMA I) and chronic (SMA II & III) forms of spinal muscular atrophy. Nature 1990, 345:823\u2013825.","journal-title":"Nature"},{"key":"16_CR9","doi-asserted-by":"crossref","first-page":"1474","DOI":"10.1126\/science.7910982","volume":"264","author":"J Melki","year":"1994","unstructured":"Melki J, Lefebvre S, Burglen L, et al.: De novo and inherited deletions of the 5q13 region in spinal muscular atrophies. Science 1994, 264:1474\u20131477.","journal-title":"Science"},{"key":"16_CR10","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1055\/s-2007-973741","volume":"27","author":"S Rudnik-Schoneborn","year":"1996","unstructured":"Rudnik-Schoneborn S, Forkert R, Hahnen E, et al.: Clinical spectrum and diagnostic criteria of infantile spinal muscular atrophy: further delineation on the basis of SMN gene deletion findings. Neuropadiatrie 1996, 27:8\u201315.","journal-title":"Neuropadiatrie"},{"key":"16_CR11","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1038\/1753","volume":"20","author":"JM Scharf","year":"1998","unstructured":"Scharf JM, Endrizzi MG, Wetter A, et al.: Identification of a candidate modifying gene for spinal muscular atrophy by comparative genomics. Nat Genet 1998, 20:83\u201386.","journal-title":"Nat Genet"},{"key":"16_CR12","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1002\/ana.410420109","volume":"42","author":"CH Wang","year":"1997","unstructured":"Wang CH, Carter TA, Das K, et al.: Extensive DNA deletion associated with severe disease alleles on spinal muscular atrophy homologues. Ann Neurol 1997, 42:41\u201349.","journal-title":"Ann Neurol"},{"key":"16_CR13","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1038\/ng1195-335","volume":"11","author":"E Bussaglia","year":"1995","unstructured":"Bussaglia E, Clermont O, Tizzano E, et al.: A frame-shift deletion in the survival motor neuron gene in Spanish spinal muscular atrophy patients. Nat Genet 1995, 11:335\u2013337.","journal-title":"Nat Genet"},{"key":"16_CR14","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1016\/0092-8674(95)90460-3","volume":"80","author":"S Lefebvre","year":"1995","unstructured":"Lefebvre S, Burglen L, Reboullet S, et al.: Identification and characterization of a spinal muscular atrophy-determining gene. Cell 1995, 80:155\u2013165.","journal-title":"Cell"},{"key":"16_CR15","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/0092-8674(95)90461-1","volume":"80","author":"N Roy","year":"1995","unstructured":"Roy N, Mahadevan MS, McLean M, et al.: The gene for neuronal apoptosis inhibitory protein is partially deleted in individuals with spinal muscular atrophy. Cell 1995, 80:167\u2013178.","journal-title":"Cell"},{"key":"16_CR16","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1002\/(SICI)1098-1004(200003)15:3<228::AID-HUMU3>3.0.CO;2-9","volume":"15","author":"B Wirth","year":"2000","unstructured":"Wirth B: An update of the mutation spectrum of the survival motor neuron gene (SMN1) in autosomal recessive spinal muscular atrophy (SMA). Hum Mutat 2000, 15:228\u2013237.","journal-title":"Hum Mutat"},{"key":"16_CR17","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1002\/mus.10050","volume":"25","author":"MB Bromberg","year":"2002","unstructured":"Bromberg MB, Swoboda KJ: Motor unit number estimation in infants and childre with spinal muscular atrophy. Muscle Nerve 2002, 25:445\u2013447. This group has determined that SMA is a neurodegenerative disease for what appears to be a self-limited period of time. However, more data from more patients are required to verify this conclusion.","journal-title":"Muscle Nerve"},{"key":"16_CR18","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1177\/088307380001500207","volume":"15","author":"ST Iannaccone","year":"2000","unstructured":"Iannaccone ST, Russman BS, Browne RH, et al.: Prospective analysis of strength in spinal muscular atrophy. J Child Neurol 2000, 15:97\u2013101. This paper represents the first prospective study of quantitative muscle strength in SMA. Because the patients were all examined after the initial neurodegenerative phase of their illness and during the stable phase, no change was seen in strength. However, the conclusions regarding design of clinical trials for SMA children over the age of 5 years are valid.","journal-title":"J Child Neurol"},{"key":"16_CR19","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1086\/513913","volume":"61","author":"AH Burghes","year":"1997","unstructured":"Burghes AH: When is a deletion not a deletion? When it is converted. Am J Hum Genet 1997, 61:9\u201315.","journal-title":"Am J Hum Genet"},{"key":"16_CR20","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1086\/513886","volume":"61","author":"L Campbell","year":"1997","unstructured":"Campbell L, Potter A, Ignatius J, et al.: Genomic variation and gene conversion in spinal muscular atrophy: implications for disease process and clinical phenotype. Am J Hum Genet 1997, 61:40\u201350.","journal-title":"Am J Hum Genet"},{"key":"16_CR21","doi-asserted-by":"crossref","first-page":"2451","DOI":"10.1093\/hmg\/9.16.2451","volume":"9","author":"UR Monani","year":"2000","unstructured":"Monani UR, Coovert DD, Burghes AH: Animal models of spinal muscular atrophy. Hum Mol Genet 2000, 9:2451\u20132457.","journal-title":"Hum Mol Genet"},{"key":"16_CR22","doi-asserted-by":"crossref","first-page":"638","DOI":"10.1007\/s003359901061","volume":"10","author":"CJ DiDonato","year":"1999","unstructured":"DiDonato CJ, Brun T, Simard LR: Complete nucleotide sequence, genomic organization, and promoter analysis of the murine survival motor neuron gene (Smn). Mamm Genome 1999, 10:638\u2013641.","journal-title":"Mamm Genome"},{"key":"16_CR23","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1038\/3030","volume":"20","author":"DK Gavrilov","year":"1998","unstructured":"Gavrilov DK, Shi X, Das K, et al.: Differential SMN2 expression associated with SMA severity. Nat Genet 1998, 20:230\u2013231.","journal-title":"Nat Genet"},{"key":"16_CR24","doi-asserted-by":"crossref","first-page":"1177","DOI":"10.1093\/hmg\/8.7.1177","volume":"8","author":"UR Monani","year":"1999","unstructured":"Monani UR, Lorson CL, Parsons DW, et al.: A single nucleotide difference that alters splicing patterns distinguishes the SMA gene SMN1 from the copy gene SMN2. Hum Molec Genet 1999, 8:1177\u20131183.","journal-title":"Hum Molec Genet"},{"key":"16_CR25","doi-asserted-by":"crossref","first-page":"6307","DOI":"10.1073\/pnas.96.11.6307","volume":"96","author":"CL Lorson","year":"1999","unstructured":"Lorson CL, Hahnen EJ, Androphy E, Wirth B: A single nucleotide in the SMN gene regulates splicing and is responsible for spinal muscular atrophy. Proc Natl Acad Sci U S A 1999, 96:6307\u20136311.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"16_CR26","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1093\/hmg\/9.2.259","volume":"9","author":"CL Lorson","year":"2000","unstructured":"Lorson CL, Androphy EJ: An exonic enhancer is required for inclusion of an essential exon in the SMA-determining gene SMN. Hum Mol Genet 2000, 9:259\u2013265.","journal-title":"Hum Mol Genet"},{"key":"16_CR27","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1038\/ng854","volume":"30","author":"L Cartegni","year":"2002","unstructured":"Cartegni L, Krainer AR: Disruption of an SF2\/ASF-dependent exonic splicing enhancer in SMN2 causes spinal muscular atrophy in the absence of SMN1. Nat Genet 2002, 30:377\u2013384.","journal-title":"Nat Genet"},{"key":"16_CR28","doi-asserted-by":"crossref","first-page":"594","DOI":"10.1101\/gad.939502","volume":"16","author":"R Lemaire","year":"2002","unstructured":"Lemaire R, Prasad J, Kashima T, et al.: Stability of a PKCI-1-related mRNA is controlled by the splicing factor ASF\/SF2: a novel function for SR proteins. Genes Dev 2002, 16:594\u2013607.","journal-title":"Genes Dev"},{"key":"16_CR29","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1006\/bbrc.1995.2135","volume":"213","author":"M Gennarelli","year":"1995","unstructured":"Gennarelli M, Lucarelli M, Capon F, et al.: Survival motor neuron gene transcript analysis in muscles from spinal muscular atrophy patients. Biochem Biophys Res Commun 1995, 213:342\u2013348.","journal-title":"Biochem Biophys Res Commun"},{"key":"16_CR30","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1038\/sj.ejhg.5200286","volume":"7","author":"AL Patrizi","year":"1999","unstructured":"Patrizi AL, Tiziano F, Zappata S, et al.: SMN protein analysis in fibroblast, amniocyte and CVS cultures from spinal muscular atrophy patients and its relevance for diagnosis. Eur J Hum Genet 1999, 7:301\u2013309.","journal-title":"Eur J Hum Genet"},{"key":"16_CR31","doi-asserted-by":"crossref","first-page":"7540","DOI":"10.1074\/jbc.M110141200","volume":"277","author":"L Pellizzoni","year":"2002","unstructured":"Pellizzoni L, Baccon J, Rappsilber J, et al.: Purification of native survival of motor neurons complexes and identification of Gemin6 as a novel component. J Biol Chem 2002, 277:7540\u20137545.","journal-title":"J Biol Chem"},{"key":"16_CR32","doi-asserted-by":"crossref","first-page":"1023","DOI":"10.1016\/S0092-8674(00)80368-2","volume":"90","author":"U Fischer","year":"1997","unstructured":"Fischer U, Liu Q, Dreyfuss G: The SMN-SIP1 complex has an essential role in spliceosomal snRNP biogenesis. Cell 1997, 90:1023\u20131029.","journal-title":"Cell"},{"key":"16_CR33","doi-asserted-by":"crossref","first-page":"1219","DOI":"10.1093\/hmg\/8.7.1219","volume":"8","author":"J Stasswimmer","year":"1999","unstructured":"Stasswimmer J, Lorson CL, Breiding DE, et al.: Identification of survival motor neuron as a transcriptional activator-binding protein. Hum Mol Genet 1999, 8:1219\u20131226.","journal-title":"Hum Mol Genet"},{"key":"16_CR34","doi-asserted-by":"crossref","first-page":"1205","DOI":"10.1093\/hmg\/6.8.1205","volume":"6","author":"D Coovert","year":"1997","unstructured":"Coovert D, Le TT, McAndrew P, et al.: The survival motor neuron protein in spinal muscular atrophy. Hum Mol Genet 1997, 6:1205\u20131214.","journal-title":"Hum Mol Genet"},{"key":"16_CR35","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1038\/ng0797-265","volume":"16","author":"S Lefebvre","year":"1997","unstructured":"Lefebvre S, Burlet P, Liu Q, et al.: Correlation between severity and SMN protein level in spinal muscular atrophy. Nat Genet 1997, 16:265\u2013269.","journal-title":"Nat Genet"},{"key":"16_CR36","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1111\/j.1750-3639.2001.tb00395.x","volume":"11","author":"H Schmalbruch","year":"2001","unstructured":"Schmalbruch H, Haase G: Spinal muscular atrophy: present state. Brain Pathol 2001, 11:231\u2013247.","journal-title":"Brain Pathol"},{"key":"16_CR37","doi-asserted-by":"crossref","first-page":"9920","DOI":"10.1073\/pnas.94.18.9920","volume":"94","author":"B Schrank","year":"1997","unstructured":"Schrank B, Gotz R, Gunnerson JM, et al.: Inactivation of the survival motor neuron gene, a candidate gene for human spinal muscular atrophy, leads to massive cell death in early mouse embryos. Proc Natl Acad Sci U S A 1997, 94:9920\u20139925.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"16_CR38","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1093\/hmg\/9.3.341","volume":"9","author":"S Jablonka","year":"2000","unstructured":"Jablonka S, Schrank B, Kralewski M, et al.: Reduced survival motor neuron (Smn) gene dose in mice leads to motor neuron degeneration: an animal model for spinal muscular atrophy type III. Hum Mol Genet 2000, 9:341\u2013346.","journal-title":"Hum Mol Genet"},{"key":"16_CR39","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1038\/71709","volume":"24","author":"HM Hsieh-Li","year":"2000","unstructured":"Hsieh-Li HM, Chang JG, Jong YJ, et al.: A mouse model for spinal muscular atrophy. Nat Genet 2000, 24:66\u201370. An independently developed valid mouse model for infantile SMA. This model has been important in understanding the role of SMN protein in disease phenotype and is currently in use for preclinical drug trials.","journal-title":"Nat Genet"},{"key":"16_CR40","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1093\/hmg\/9.3.333","volume":"9","author":"UR Monani","year":"2000","unstructured":"Monani UR, Sendtner M, Coovert DD, et al.: The human centromeric survival motor neuron gene (SMN2) rescues embryonic lethality in Smn(-\/-) mice and results in a mouse with spinal muscular atrophy. Hum Mol Genet 2000, 9:333\u2013339. An independently developed valid mouse model for infantile SMA. This model has been important in understanding the role of SMN protein in disease phenotype and is currently in use for preclinical drug trials.","journal-title":"Hum Mol Genet"},{"key":"16_CR41","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1083\/jcb.200208079","volume":"160","author":"UR Monani","year":"2003","unstructured":"Monani UR, Pastore MT, et al.: A transgene carrying an A2G missense mutation in the SMN gene modulates phenotypic severity in mice with severe (type I) spinal muscular atrophy. J Cell Biol 2003, 160:41\u201352.","journal-title":"J Cell Biol"},{"key":"16_CR42","doi-asserted-by":"crossref","first-page":"849","DOI":"10.1093\/hmg\/9.5.849","volume":"9","author":"T Frugier","year":"2000","unstructured":"Frugier T, Tiziano FD, Cifuentes-Diaz C, et al.: Nuclear targeting defect of SMN lacking the C-terminus in a mouse model of spinal muscular atrophy. Hum Mol Genet 2000, 9:849\u2013858.","journal-title":"Hum Mol Genet"},{"key":"16_CR43","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1002\/mus.10110","volume":"26","author":"S Nicole","year":"2002","unstructured":"Nicole S, Diaz CC, Frugier T, Melki J: Spinal muscular atrophy: recent advances and future prospects. Muscle Nerve 2002, 26:4\u201313.","journal-title":"Muscle Nerve"},{"key":"16_CR44","unstructured":"Salah N, Desforges B, Cifuentes-Diaz C, et al.: Therapeutic research strategies in SMA mouse models [abstract]. Presented at Sixth Annual International Spinal Muscular Atrophy Research Group Meeting. Chicago, IL, 2002."},{"key":"16_CR45","unstructured":"Jarecki J, Chen J, Whitney M, et al.: Identification and profiling of compounds that increase full-length SMN2 nRNA levels [abstract]. Presented at Sixth Annual International Spinal Muscular Atrophy Research Group Meeting. Chicago, IL, 2002."},{"key":"16_CR46","unstructured":"Markowitz JA, Coovert DD, Schussler K, et al.: Valproic acid increases SMN levels in SMA fibroblasts [abstract]. Presented at Sixth Annual International Spinal Muscular Atrophy Research Group Meeting. Chicago, IL, 2002."},{"key":"16_CR47","doi-asserted-by":"crossref","first-page":"4640","DOI":"10.1182\/blood-2002-02-0353","volume":"100","author":"BS Pace","year":"2002","unstructured":"Pace BS, White GL, Dover GJ, et al.: Short-chain fatty acid derivatives induce fetal globin expression and erythropoiesis in vivo. Blood 2002, 100:4640\u20134648.","journal-title":"Blood"},{"key":"16_CR48","doi-asserted-by":"crossref","first-page":"2075","DOI":"10.1182\/blood.V90.5.2075","volume":"90","author":"PG McCaffrey","year":"1997","unstructured":"McCaffrey PG, Newsome DA, Fibach E, et al.: Induction of gamma-globin by histone deacetylase inhibitors. Blood 1997, 90:2075\u20132083.","journal-title":"Blood"},{"key":"16_CR49","doi-asserted-by":"crossref","first-page":"9808","DOI":"10.1073\/pnas.171105098","volume":"98","author":"JG Chang","year":"2001","unstructured":"Chang JG, Hsieh-Li HM, Jong YJ, et al.: Treatment of spinal muscular atrophy by sodium butyrate. Proc Natl Acad Sci U S A 2001, 98:9808\u20139813.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"16_CR50","doi-asserted-by":"crossref","first-page":"2841","DOI":"10.1093\/hmg\/10.24.2841","volume":"10","author":"C Andreassi","year":"2001","unstructured":"Andreassi C, Jarecki J, Zhou J, et al.: Aclarubicin treatment restores SMN levels to cells derived from type 1 spinal muscular atrophy patients. Hum Molec Genet 2001, 10:2841\u20132849.","journal-title":"Hum Molec Genet"},{"key":"16_CR51","first-page":"393","volume":"21","author":"D Richard","year":"2002","unstructured":"Richard D, Hollender P, Chenais B: Involvement of reactive oxygen species in aclarubicin-induced differentiation and invasiveness of HL-60 leukemia cells. Int J Oncol 2002, 21:393\u2013399.","journal-title":"Int J Oncol"},{"key":"16_CR52","doi-asserted-by":"crossref","first-page":"973","DOI":"10.1212\/WNL.47.4.973","volume":"47","author":"BS Russman","year":"1996","unstructured":"Russman BS, Buncher CR, White M, et al.: Function changes in spinal muscular atrophy II and III. The DCN\/SMA Group. Neurology 1996, 47:973\u2013976.","journal-title":"Neurology"},{"key":"16_CR53","first-page":"502","volume":"30","author":"ST Iannaccone","year":"1991","unstructured":"Iannaccone ST, Russman BS, Samaha F, et al.: Spinal muscular atrophy: functional testing before age 5. Ann Neurol 1991, 30:502.","journal-title":"Ann Neurol"},{"key":"16_CR54","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1177\/088307389400900321","volume":"9","author":"FJ Samaha","year":"1994","unstructured":"Samaha FJ, Buncher CR, Russman BS, et al.: Pulmonary function in spinal muscular atrophy. J Child Neurol 1994, 9:326\u2013329.","journal-title":"J Child Neurol"},{"key":"16_CR55","first-page":"175","volume":"6","author":"L Barker","year":"1992","unstructured":"Barker L, Smith C, Perkins B, et al.: Clinical trials in spinal muscular atrophy: Protocol development and reliability of quantitative strength assessment method. J Neurol Rehab 1992, 6:175\u2013183.","journal-title":"J Neurol Rehab"},{"key":"16_CR56","doi-asserted-by":"crossref","first-page":"S11","DOI":"10.1002\/mus.880131305","volume":"13","author":"F Samaha","year":"1990","unstructured":"Samaha F, Cook JD, Iannaccone ST, et al.: Preliminary observations on the reliability of the DCN-SMA Study Group methodology. Muscle Nerve 1990, 13:S11-S12.","journal-title":"Muscle Nerve"},{"key":"16_CR57","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1177\/088307389200700403","volume":"7","author":"BS Russman","year":"1992","unstructured":"Russman BS, Iannaccone ST, Buncher CR, et al.: Spinal muscular atrophy: new thoughts on the pathogenesis and classification schema. J Child Neurol 1992, 7:347\u2013353.","journal-title":"J Child Neurol"},{"key":"16_CR58","unstructured":"Bassanini S, Setola V, Giavazzi A, Battaglia G: The SMN protein is specifically localized in neuritic extensions of cultured motor neurons [abstract]. Presented at Sixth Annual International Spinal Muscular Atrophy Research Group Meeting. Chicago, IL, 2002."},{"key":"16_CR59","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1177\/088307389701200507","volume":"12","author":"ST Iannaccone","year":"1997","unstructured":"Iannaccone ST, White M, Browne R, et al.: Muscle fatigue in spinal muscular atrophy. J Child Neurol 1997, 12:321\u2013326.","journal-title":"J Child Neurol"},{"key":"16_CR60","first-page":"127","volume":"191","author":"RG Miller","year":"2001","unstructured":"Miller RG, Moore DH, Dronsky V, et al.: A placebo-controlled trial of gabapentin in spinal muscular atrophy. J Neurosci 2001, 191:127\u2013131.","journal-title":"J Neurosci"},{"key":"16_CR61","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1056\/NEJM199403033300901","volume":"330","author":"G Bensimon","year":"1994","unstructured":"Bensimon G, Lacomblez L, Meininger V, for the ALS\/Riluzole Study Group: A controlled trial of riluzole in amyotrophic lateral sclerosis. N Engl J Med 1994, 330:585\u2013591.","journal-title":"N Engl J Med"},{"key":"16_CR62","doi-asserted-by":"crossref","first-page":"S86","DOI":"10.1212\/WNL.47.4_Suppl_2.86S","volume":"47","author":"RG Miller","year":"1996","unstructured":"Miller RG, Bouchard JP, Duquette P, et al.: Clinical trials of riluzole in patients with amyotrophic lateral sclerosis. Neurology 1996, 47:S86-S92.","journal-title":"Neurology"},{"key":"16_CR63","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1046\/j.1471-4159.1995.65020643.x","volume":"65","author":"JD Rothstein","year":"1995","unstructured":"Rothstein JD, Kuncl RW: Neuroprotective strategies in a model of chronic glutamate-mediated motor neuron toxicity. J Neurochem 1995, 65:643\u2013651.","journal-title":"J Neurochem"},{"key":"16_CR64","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1016\/S0140-6736(96)03181-9","volume":"348","author":"J Wokke","year":"1996","unstructured":"Wokke J: Riluzole. Lancet 1996, 348:795\u2013799.","journal-title":"Lancet"},{"key":"16_CR65","doi-asserted-by":"crossref","unstructured":"Russman BS, Iannaccone ST, Samaha FJ: A phase one trial of riluzole in spinal muscular atrophy [abstract]. Arch Neurol 2003, 8.","DOI":"10.1001\/archneur.60.11.1601"},{"key":"16_CR66","doi-asserted-by":"crossref","first-page":"432","DOI":"10.1002\/mus.10455","volume":"28","author":"H Haddad","year":"2003","unstructured":"Haddad H, Cifuentes-Diaz C, Miroglio A, et al.: Riluzole attenuates spinal muscular atrophy disease progression in a mouse model. Muscle Nerve 2003, 28:432\u2013437.","journal-title":"Muscle Nerve"},{"key":"16_CR67","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1212\/WNL.59.4.609","volume":"59","author":"M Kinali","year":"2002","unstructured":"Kinali M, Mercuri E, Main M, et al.: Pilot trial of albuterol in spinal muscular atrophy. Neurology 2002, 59:609\u2013610.","journal-title":"Neurology"},{"key":"16_CR68","doi-asserted-by":"crossref","first-page":"854","DOI":"10.1212\/WNL.52.4.854","volume":"52","author":"M Tarnopolsky","year":"1999","unstructured":"Tarnopolsky M, Martin J: Creatine monohydrate increases strength in patients with neuromuscular disease. Neurology 1999, 52:854\u2013857.","journal-title":"Neurology"},{"key":"16_CR69","doi-asserted-by":"crossref","first-page":"1848","DOI":"10.1212\/WNL.54.9.1848","volume":"54","author":"MC Walter","year":"2000","unstructured":"Walter MC, Lochmuller H, Reilich P, et al.: Creatine monohydrate in muscular dystrophies: a double-blind, placebo-controlled clinical study. Neurology 2000, 54:1848\u20131850.","journal-title":"Neurology"},{"key":"16_CR70","doi-asserted-by":"crossref","first-page":"1130","DOI":"10.1001\/archneur.60.8.1130","volume":"60","author":"LS Hynan","year":"2003","unstructured":"Hynan LS, Iannaccone ST: Reliability of four outcome measures in pediatric spinal muscular atrophy [abstract]. Arch Neurol 2003, 60:1130\u20131136.","journal-title":"Arch Neurol"},{"key":"16_CR71","doi-asserted-by":"crossref","first-page":"1445","DOI":"10.1001\/archneur.59.9.1445","volume":"59","author":"ST Iannaccone","year":"2002","unstructured":"Iannaccone ST: Outcome measures for pediatric spinal muscular atrophy. Arch Neurol 2002, 59:1445\u20131450.","journal-title":"Arch Neurol"},{"key":"16_CR72","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1017\/S0012162201002043","volume":"44","author":"SK Campbell","year":"2002","unstructured":"Campbell SK, Kolobe TH, Wright BD, Linacre JM: Validity of the Test of Infant Motor Performance for prediction of 6-, 9- and 12-month scores on the Alberta Infant Motor Scale. Dev Med Child Neurol 2002, 44:263\u2013272.","journal-title":"Dev Med Child Neurol"},{"key":"16_CR73","doi-asserted-by":"crossref","first-page":"1538","DOI":"10.1378\/chest.105.5.1538","volume":"105","author":"JR Bach","year":"1994","unstructured":"Bach JR: Update and perspective on noninvasive respiratory muscle aids. Chest 1994, 105:1538\u20131544.","journal-title":"Chest"},{"key":"16_CR74","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1378\/chest.97.1.52","volume":"97","author":"JR Bach","year":"1990","unstructured":"Bach JR: Management of chronic alveolar hypoventilation by nasal ventilation. Chest 1990, 97:52\u201357.","journal-title":"Chest"},{"key":"16_CR75","doi-asserted-by":"crossref","first-page":"630","DOI":"10.1378\/chest.99.3.630","volume":"99","author":"JR Bach","year":"1991","unstructured":"Bach JR, Alba AS: Intermittent abdominal pressure ventilator in a regimen of noninvasive ventilatory support. Chest 1991, 99:630\u2013636.","journal-title":"Chest"},{"key":"16_CR76","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1097\/00002060-199406000-00010","volume":"73","author":"TG Wang","year":"1994","unstructured":"Wang TG, Bach JR, Avilla C, et al.: Survival of individuals with spinal muscular atrophy on ventilatory support. Am J Phys Med Rehabil 1994, 73:207\u2013211.","journal-title":"Am J Phys Med Rehabil"},{"key":"16_CR77","first-page":"44","volume":"207","author":"JO Piasecki","year":"1986","unstructured":"Piasecki JO, Mahinpour S, Levine DB: Long-term follow-up of spinal fusion in spinal muscular atrophy. Clin Orthoped Rel Res 1986, 207:44\u201354.","journal-title":"Clin Orthoped Rel Res"},{"key":"16_CR78","doi-asserted-by":"crossref","first-page":"1179","DOI":"10.2106\/00004623-198264080-00008","volume":"64A","author":"H Aprin","year":"1982","unstructured":"Aprin H, Bowen JR, MacEwen GD, Hall JE: Spine fusion in patients with spinal muscular atrophy. J Bone Joint Surg 1982, 64A:1179\u20131187.","journal-title":"J Bone Joint Surg"},{"key":"16_CR79","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1097\/01241398-198507000-00001","volume":"5","author":"YH Daher","year":"1985","unstructured":"Daher YH, Lonstein JE, Winter RB, Bradford DS: Spinal surgery in spinal muscular atrophy. J Pediatr Orthoped 1985, 5:391\u2013395.","journal-title":"J Pediatr Orthoped"},{"key":"16_CR80","doi-asserted-by":"crossref","first-page":"973","DOI":"10.1212\/WNL.47.4.973","volume":"47","author":"BS Russman","year":"1996","unstructured":"Russman BS, Buncher CR, White M, et al., for the DCN\/SMA Group: Function changes in spinal muscular atrophy II and III. Neurology 1996, 47:973\u2013976.","journal-title":"Neurology"},{"key":"16_CR81","first-page":"418","volume":"65","author":"IM Siegel","year":"1984","unstructured":"Siegel IM, Silverman M: Upright mobility system for spinal muscular atrophy patients. Arch Phys Med Rehabil 1984, 65:418.","journal-title":"Arch Phys Med Rehabil"},{"key":"16_CR82","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1111\/j.1469-8749.1987.tb02138.x","volume":"29","author":"TB Whelan","year":"1987","unstructured":"Whelan TB: Neuropsychological performance of children with Duchenne muscular dystrophy and spinal muscle atrophy. Dev Med Child Neurol 1987, 29:212\u2013220.","journal-title":"Dev Med Child Neurol"}],"container-title":["Current Neurology and Neuroscience Reports"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11910-004-0016-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s11910-004-0016-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11910-004-0016-6","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,4,22]],"date-time":"2020-04-22T11:16:40Z","timestamp":1587554200000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s11910-004-0016-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2004,1]]},"references-count":82,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2004,1]]}},"alternative-id":["16"],"URL":"https:\/\/doi.org\/10.1007\/s11910-004-0016-6","relation":{},"ISSN":["1528-4042","1534-6293"],"issn-type":[{"value":"1528-4042","type":"print"},{"value":"1534-6293","type":"electronic"}],"subject":[],"published":{"date-parts":[[2004,1]]}}}